LON:MPHMereo BioPharma Group Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Mereo BioPharma Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 46 -0.50 (-1.08 %) (As of 07/14/2020) Add Compare Share Today's Range 43.50Now: GBX 46▼ 4650-Day Range 39.50MA: GBX 46.42▼ 4952-Week Range 0.45Now: GBX 46▼ 75Volume16,200 shsAverage Volume266 shsMarket Capitalization£155.81 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsInsider TradesHeadlines Mereo BioPharma Group plc, a specialty biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of rare and specialty diseases. Its product candidates include BPS-804, a monoclonal antibody, which is in Phase IIb clinical trial for the treatment of osteogenesis imperfecta; AZD-9668, an oral small molecule that has been completed Phase I clinical trial to treat Alpha-1 antitrypsin deficiency; BGS-649, an oral aromatase inhibitor, which is in Phase IIb clinical trial for the treatment of hypogonadal hypogonadism; and BCT-197, an oral p38 MAP kinase inhibitor that is in Phase II clinical trial to treat acute exacerbations of chronic obstructive pulmonary disease. Mereo BioPharma Group plc was founded in 2015 and is headquartered in London, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Mereo BioPharma Group. Previous Next 2.8 Community Rank Outperform VotesMereo BioPharma Group has received 123 “outperform” votes. (Add your “outperform” vote.)Underperform VotesMereo BioPharma Group has received 98 “underperform” votes. (Add your “underperform” vote.)Community SentimentMereo BioPharma Group has received 55.66% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Mereo BioPharma Group and other stocks. Vote “Outperform” if you believe MPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MPH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldMereo BioPharma Group does not currently pay a dividend.Dividend GrowthMereo BioPharma Group does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Mereo BioPharma Group insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Mereo BioPharma Group is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Mereo BioPharma Group is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMereo BioPharma Group has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.56 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:MPH Previous Symbol CUSIPN/A CIKN/A Webmereobiopharma.com Phone44 33 3023 7300Debt Debt-to-Equity Ratio80.53 Current Ratio1.02 Quick Ratio0.94Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 7.78 per share Price / Cash Flow5.91 Book ValueGBX 41.10 per share Price / Book1.12Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees31 Outstanding Shares338,713,984Market Cap£155.81 million Next Earnings DateN/A OptionableNot Optionable GBX 46 -0.50 (-1.08 %) (As of 07/14/2020) 30 days | 90 days | 365 days | Advanced Chart Receive MPH News and Ratings via Email Sign-up to receive the latest news and ratings for MPH and its competitors with MarketBeat's FREE daily newsletter. Mereo BioPharma Group (LON:MPH) Frequently Asked Questions How has Mereo BioPharma Group's stock been impacted by COVID-19 (Coronavirus)? Mereo BioPharma Group's stock was trading at GBX 25.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MPH stock has increased by 80.4% and is now trading at GBX 46. View which stocks have been most impacted by Coronavirus. How were Mereo BioPharma Group's earnings last quarter? Mereo BioPharma Group PLC (LON:MPH) announced its earnings results on Tuesday, June, 16th. The company reported ($39.00) EPS for the quarter, missing the consensus estimate of ($27.50) by $11.50. View Mereo BioPharma Group's earnings history. Has Mereo BioPharma Group been receiving favorable news coverage? Headlines about MPH stock have been trending somewhat negative on Tuesday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Mereo BioPharma Group earned a daily sentiment score of -1.7 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future. View the latest news about Mereo BioPharma Group. Who are some of Mereo BioPharma Group's key competitors? Some companies that are related to Mereo BioPharma Group include Aptose Biosciences (APS), SIGA Technologies (SIGA), Ibio (IBIO), CEL-SCI (CVM), Paradigm Biopharmaceuticals (PAR), Biotest (BIO), IMV (IMV), Neptune Wellness Solutions (NEPT), Nkarta (IVA), Tiziana Life Sciences (TILS), Silence Therapeutics (SLN), TELIX Pharmaceutical (TLX), Starpharma (SPL), ProMetic Life Sciences (PLI) and IMV (IMV). View all competitors. What other stocks do shareholders of Mereo BioPharma Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Mereo BioPharma Group investors own include Enanta Pharmaceuticals (ENTA), ARMOUR Residential REIT (ARR), Arena Pharmaceuticals (ARNA), Ardelyx (ARDX), Algonquin Power & Utilities (AQN), Anworth Mortgage Asset Corp Reit (ANH), American Tower (AMT), Amgen (AMGN), Advanced Micro Devices (AMD) and AGNC Investment (AGNC). Who are Mereo BioPharma Group's key executives? Mereo BioPharma Group's management team includes the following people: Dr. Denise Scots-Knight, Co-Founder, Chief Exec. Officer & Exec. Director (Age 60)Mr. Richard Crispin Morgan Jones, CFO & Exec. Director (Age 53)Mr. Charles Sermon, Co-Founder, Gen. Counsel & Company Sec. (Age 50)Dr. Alastair MacKinnon, Co-Founder & Chief Medical Officer (Age 49)Mr. John Richard, Co-Founder & Head of Corp. Devel. (Age 62) What is Mereo BioPharma Group's stock symbol? Mereo BioPharma Group trades on the London Stock Exchange (LON) under the ticker symbol "MPH." How do I buy shares of Mereo BioPharma Group? Shares of MPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Mereo BioPharma Group's stock price today? One share of MPH stock can currently be purchased for approximately GBX 46. How big of a company is Mereo BioPharma Group? Mereo BioPharma Group has a market capitalization of £155.81 million. Mereo BioPharma Group employs 31 workers across the globe. What is Mereo BioPharma Group's official website? The official website for Mereo BioPharma Group is mereobiopharma.com. How can I contact Mereo BioPharma Group? Mereo BioPharma Group's mailing address is 1 Cavendish Place, LONDON, W1G 0QF, United Kingdom. The company can be reached via phone at 44 33 3023 7300. This page was last updated on 8/4/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
